Helmy Eltoukhy is the chairman, co-CEO and chairman of the board of directors for the leading precision oncology company Guardant Health, which he co-founded in 2012 with Dr. AmirAli Talasaz.

In 2007, Eltoukhy co-founded his previous startup Avantome to commercialize semiconductor sequencing, which was acquired by Illumina. While at Illumina, Eltoukhy served as Senior Director of Advanced Technology Research, where he developed novel chemistries, hardware, and informatics for genetic analysis systems.

Eltoukhy began his career at the Stanford Genome Technology Center, where he invented the first semiconductor sequencing platform and the first base-calling algorithm for next-gen sequencing. He received his PhD, MS and BS degrees in electrical engineering from Stanford University.

Health, Healthcare, Healthcare Policy, Business of Healthcare, Innovation, Science, Technology, Genetics, Cancer, Startup, Chief Executive Officer (CEO), CEO, Co-founder